Gevo Confirms Nasdaq Listing for Common Stock
Ticker: GEVO · Form: 8-K · Filed: Jan 24, 2024 · CIK: 1392380
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, exchange-listing, corporate-governance
TL;DR
**GEVO's stock is still listed on Nasdaq, business as usual.**
AI Summary
Gevo, Inc. filed an 8-K on January 24, 2024, primarily to disclose that its common stock, with a par value of $0.01 per share, is registered on the Nasdaq Capital Market under the trading symbol GEVO. This filing also confirms the company's basic identifying information, such as its Delaware incorporation and business address in Englewood, CO. For investors, this matters because it reaffirms Gevo's continued listing on a major exchange, providing liquidity and visibility for its shares.
Why It Matters
This filing confirms Gevo's continued compliance with listing requirements, which is crucial for maintaining investor confidence and ensuring the stock remains easily tradable on a recognized exchange.
Risk Assessment
Risk Level: low — This 8-K is a routine administrative filing confirming existing information and does not introduce new financial risks or operational changes.
Analyst Insight
This filing is largely administrative, confirming existing information. Smart investors would note the continued Nasdaq listing ensures liquidity but should look to other filings for material operational or financial updates before making investment decisions.
Key Numbers
- $0.01 — Par Value per Share (The stated par value of Gevo, Inc.'s common stock.)
Key Players & Entities
- Gevo, Inc. (company) — the registrant filing the 8-K
- Nasdaq Capital Market (company) — the exchange where Gevo's common stock is registered
- GEVO (company) — the trading symbol for Gevo, Inc.'s common stock
- $0.01 (dollar_amount) — par value per share of common stock
- January 24, 2024 (date) — date of earliest event reported and filing date
Forward-Looking Statements
- Gevo, Inc. will maintain its listing on the Nasdaq Capital Market. (Gevo, Inc.) — high confidence, target: 2025-01-24
FAQ
What is the primary purpose of Gevo, Inc.'s 8-K filing dated January 24, 2024?
The primary purpose of Gevo, Inc.'s 8-K filing dated January 24, 2024, is to report on 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure,' and to confirm that its Common Stock, par value $0.01 per share, is registered on the Nasdaq Capital Market under the trading symbol GEVO.
On which stock exchange is Gevo, Inc.'s common stock traded?
Gevo, Inc.'s common stock is traded on the Nasdaq Capital Market, as stated in the filing under 'Name of exchange on which registered'.
What is the trading symbol for Gevo, Inc. on the Nasdaq Capital Market?
The trading symbol for Gevo, Inc. on the Nasdaq Capital Market is GEVO, as indicated in the 'Trading symbol' section of the filing.
What is the par value of Gevo, Inc.'s common stock?
The par value of Gevo, Inc.'s common stock is $0.01 per share, as specified in the filing under 'Common Stock, par value $0.01 per share'.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is January 24, 2024, as stated under 'Date of Report (Date of earliest event reported): January 24, 2024'.
Filing Stats: 530 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-01-24 09:10:11
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share GEVO Nasdaq Capital Mark
Filing Documents
- tm243971d1_8k.htm (8-K) — 24KB
- tm243971d1_ex99-1.htm (EX-99.1) — 41KB
- tm243971d1_ex99-1img001.jpg (GRAPHIC) — 10KB
- 0001104659-24-006122.txt ( ) — 258KB
- gevo-20240124.xsd (EX-101.SCH) — 3KB
- gevo-20240124_lab.xml (EX-101.LAB) — 33KB
- gevo-20240124_pre.xml (EX-101.PRE) — 22KB
- tm243971d1_8k_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 24, 2024, Gevo, Inc. (the "Company") issued a press release providing a business update and announcing certain preliminary unaudited financial information for its year ended December 31, 2023. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. The information set forth under Item 2.02 is incorporated by reference into this Item 7.01. The information in Items 2.02 and 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated January 24, 2024 104 Cover Page Interactive Data File (Formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GEVO, INC. Dated: January 24, 2024 By: /s/ E. Cabell Massey E. Cabell Massey Vice President, Legal and Corporate Secretary